Tech Company Financing Transactions
Outpost Medicine Funding Round
Outpost Medicine closed a $20 million Series A financing round on 11/16/2017. Backers included Adams Street Partners, Frazier Healthcare Partners and Novo Ventures.
Transaction Overview
Company Name
Announced On
11/16/2017
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds from the Series A extension enable Outpost to shift focus to OP-687, a new class of oral therapy in development for the treatment overactive bladder (OAB) and irritable bowel syndrome (IBS).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Outpost Medicine is developing treatments for urologic and gynecologic diseases and disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Socks
Browse more venture capital transactions:
Prev: 11/16/2017: Nudge Rewards venture capital transaction
Next: 11/16/2017: eASIC venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here come from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs